APO Research
Talk to an analyst

APO RESEARCH · REPORT

Luseogliflozin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Luseogliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025178 pages

Choose your research edition.

Industry ResearchLuseogliflozin Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Luseogliflozin Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Luseogliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Luseogliflozin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Luseogliflozin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Luseogliflozin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Luseogliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Luseogliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Luseogliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Luseogliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Luseogliflozin include Taisho Toyama, Novartis, Mitsubishi Tanabe Pharma and CR Double-Crane, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Luseogliflozin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Luseogliflozin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Luseogliflozin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Luseogliflozin market size, projected growth trends, production technologies, key applications, and end-use industries.

Luseogliflozin Segment by Company

Taisho Toyama

Novartis

Mitsubishi Tanabe Pharma

CR Double-Crane

Luseogliflozin Segment by Type

2.5mg

5mg

Luseogliflozin Segment by Application

Periodontitis

Heart Disease

Diabetes

Luseogliflozin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Luseogliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Luseogliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Luseogliflozin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Luseogliflozin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Luseogliflozin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Luseogliflozin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Luseogliflozin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Luseogliflozin Industry Trends Table 2. Luseogliflozin Industry Drivers Table 3. Luseogliflozin Industry Opportunities and Challenges Table 4. Luseogliflozin Industry Restraints Table 5. Global Luseogliflozin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Luseogliflozin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Luseogliflozin Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Luseogliflozin Sales Market Share by Manufacturers Table 9. Global Luseogliflozin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Luseogliflozin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Luseogliflozin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Luseogliflozin Manufacturers, Product Type & Application Table 13. Global Luseogliflozin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Luseogliflozin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2.5mg Table 17. Major Manufacturers of 5mg Table 18. Global Luseogliflozin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Luseogliflozin Sales by Type (2021-2026) & (K Units) Table 20. Global Luseogliflozin Sales by Type (2027-2032) & (K Units) Table 21. Global Luseogliflozin Sales Market Share by Type (2021-2026) Table 22. Global Luseogliflozin Sales Market Share by Type (2027-2032) Table 23. Global Luseogliflozin Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Luseogliflozin Revenue by Type (2021-2026) & (K Units) Table 25. Global Luseogliflozin Revenue by Type (2027-2032) & (K Units) Table 26. Global Luseogliflozin Revenue Market Share by Type (2021-2026) Table 27. Global Luseogliflozin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Periodontitis Table 29. Major Manufacturers of Heart Disease Table 30. Major Manufacturers of Diabetes Table 31. Global Luseogliflozin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Luseogliflozin Sales by Application (2021-2026) & (K Units) Table 33. Global Luseogliflozin Sales by Application (2027-2032) & (K Units) Table 34. Global Luseogliflozin Sales Market Share by Application (2021-2026) Table 35. Global Luseogliflozin Sales Market Share by Application (2027-2032) Table 36. Global Luseogliflozin Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Luseogliflozin Revenue by Application (2021-2026) & (K Units) Table 38. Global Luseogliflozin Revenue by Application (2027-2032) & (K Units) Table 39. Global Luseogliflozin Revenue Market Share by Application (2021-2026) Table 40. Global Luseogliflozin Revenue Market Share by Application (2027-2032) Table 41. Global Luseogliflozin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Luseogliflozin Sales by Region (2021-2026) & (K Units) Table 43. Global Luseogliflozin Sales Market Share by Region (2021-2026) Table 44. Global Luseogliflozin Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Luseogliflozin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Luseogliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 48. North America Luseogliflozin Sales by Country (2027-2032) & (K Units) Table 49. Europe Luseogliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 51. Europe Luseogliflozin Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Luseogliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Luseogliflozin Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Luseogliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Luseogliflozin Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Luseogliflozin Sales by Country (2027-2032) & (K Units) Table 58. Global Luseogliflozin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Luseogliflozin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Luseogliflozin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Luseogliflozin Revenue Market Share by Region (2021-2026) Table 62. Global Luseogliflozin Revenue Market Share by Region (2027-2032) Table 63. Taisho Toyama Company Information Table 64. Taisho Toyama Business Overview Table 65. Taisho Toyama Luseogliflozin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Taisho Toyama Luseogliflozin Product Portfolio Table 67. Taisho Toyama Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Luseogliflozin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis Luseogliflozin Product Portfolio Table 72. Novartis Recent Development Table 73. Mitsubishi Tanabe Pharma Company Information Table 74. Mitsubishi Tanabe Pharma Business Overview Table 75. Mitsubishi Tanabe Pharma Luseogliflozin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Mitsubishi Tanabe Pharma Luseogliflozin Product Portfolio Table 77. Mitsubishi Tanabe Pharma Recent Development Table 78. CR Double-Crane Company Information Table 79. CR Double-Crane Business Overview Table 80. CR Double-Crane Luseogliflozin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CR Double-Crane Luseogliflozin Product Portfolio Table 82. CR Double-Crane Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Luseogliflozin Distributors List Table 86. Luseogliflozin Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Luseogliflozin Product Image Figure 2. Global Luseogliflozin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Luseogliflozin Market Size (2021-2032) & (US$ Million) Figure 4. Global Luseogliflozin Sales (2021-2032) & (K Units) Figure 5. Global Luseogliflozin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Luseogliflozin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2.5mg Image Figure 9. 5mg Image Figure 10. Global Luseogliflozin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Luseogliflozin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Luseogliflozin Sales Market Share by Type (2021-2032) Figure 13. Global Luseogliflozin Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Luseogliflozin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Luseogliflozin Revenue Market Share by Type (2021-2032) Figure 16. Periodontitis Image Figure 17. Heart Disease Image Figure 18. Diabetes Image Figure 19. Global Luseogliflozin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Luseogliflozin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Luseogliflozin Sales Market Share by Application (2021-2032) Figure 22. Global Luseogliflozin Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Luseogliflozin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Luseogliflozin Revenue Market Share by Application (2021-2032) Figure 25. North America Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Luseogliflozin Sales Market Share by Country (2021-2032) Figure 27. U.S. Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Luseogliflozin Sales Market Share by Country (2021-2032) Figure 32. Germany Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Luseogliflozin Sales Market Share by Country (2021-2032) Figure 39. China Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Luseogliflozin Sales Market Share by Country (2021-2032) Figure 47. Brazil Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Luseogliflozin Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Luseogliflozin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Luseogliflozin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Luseogliflozin Revenue (2021-2032) & (US$ Million) Figure 58. North America Luseogliflozin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Luseogliflozin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Luseogliflozin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Luseogliflozin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Luseogliflozin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Luseogliflozin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Luseogliflozin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Luseogliflozin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Luseogliflozin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg
  • 5mg
Applications
  • Periodontitis
  • Heart Disease
  • Diabetes
Companies covered
  • Taisho Toyama
  • Novartis
  • Mitsubishi Tanabe Pharma
  • CR Double-Crane

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Luseogliflozin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Luseogliflozin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Luseogliflozin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Luseogliflozin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Luseogliflozin Market Dynamics
  1. 2.1 Luseogliflozin Industry Trends
  2. 2.2 Luseogliflozin Industry Drivers
  3. 2.3 Luseogliflozin Industry Opportunities and Challenges
  4. 2.4 Luseogliflozin Industry Restraints
3 Luseogliflozin Market by Manufacturers
  1. 3.1 Global Luseogliflozin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Luseogliflozin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Luseogliflozin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Luseogliflozin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Luseogliflozin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Luseogliflozin Manufacturers, Product Type & Application
  7. 3.7 Global Luseogliflozin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Luseogliflozin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Luseogliflozin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Luseogliflozin Tier 1, Tier 2, and Tier 3
4 Luseogliflozin Market by Type
  1. 4.1 Luseogliflozin Type Introduction
  2. 4.1.1 2.5mg
  3. 4.1.2 5mg
  4. 4.2 Global Luseogliflozin Sales by Type
  5. 4.2.1 Global Luseogliflozin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Luseogliflozin Sales by Type (2021-2032)
  7. 4.2.3 Global Luseogliflozin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Luseogliflozin Revenue by Type
  9. 4.3.1 Global Luseogliflozin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Luseogliflozin Revenue by Type (2021-2032)
  11. 4.3.3 Global Luseogliflozin Revenue Market Share by Type (2021-2032)
5 Luseogliflozin Market by Application
  1. 5.1 Luseogliflozin Application Introduction
  2. 5.1.1 Periodontitis
  3. 5.1.2 Heart Disease
  4. 5.1.3 Diabetes
  5. 5.2 Global Luseogliflozin Sales by Application
  6. 5.2.1 Global Luseogliflozin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Luseogliflozin Sales by Application (2021-2032)
  8. 5.2.3 Global Luseogliflozin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Luseogliflozin Revenue by Application
  10. 5.3.1 Global Luseogliflozin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Luseogliflozin Revenue by Application (2021-2032)
  12. 5.3.3 Global Luseogliflozin Revenue Market Share by Application (2021-2032)
6 Global Luseogliflozin Sales by Region
  1. 6.1 Global Luseogliflozin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Luseogliflozin Sales by Region (2021-2032)
  3. 6.2.1 Global Luseogliflozin Sales by Region (2021-2026)
  4. 6.2.2 Global Luseogliflozin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Luseogliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Luseogliflozin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Luseogliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Luseogliflozin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Luseogliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Luseogliflozin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Luseogliflozin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Luseogliflozin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Luseogliflozin Revenue by Region
  1. 7.1 Global Luseogliflozin Revenue by Region
  2. 7.1.1 Global Luseogliflozin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Luseogliflozin Revenue by Region (2021-2026)
  4. 7.1.3 Global Luseogliflozin Revenue by Region (2027-2032)
  5. 7.1.4 Global Luseogliflozin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Luseogliflozin Revenue (2021-2032)
  8. 7.2.2 North America Luseogliflozin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Luseogliflozin Revenue (2021-2032)
  11. 7.3.2 Europe Luseogliflozin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Luseogliflozin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Luseogliflozin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Luseogliflozin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Luseogliflozin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Taisho Toyama
  2. 8.1.1 Taisho Toyama Company Information
  3. 8.1.2 Taisho Toyama Business Overview
  4. 8.1.3 Taisho Toyama Luseogliflozin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Taisho Toyama Luseogliflozin Product Portfolio
  6. 8.1.5 Taisho Toyama Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Luseogliflozin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Luseogliflozin Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Mitsubishi Tanabe Pharma
  14. 8.3.1 Mitsubishi Tanabe Pharma Company Information
  15. 8.3.2 Mitsubishi Tanabe Pharma Business Overview
  16. 8.3.3 Mitsubishi Tanabe Pharma Luseogliflozin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mitsubishi Tanabe Pharma Luseogliflozin Product Portfolio
  18. 8.3.5 Mitsubishi Tanabe Pharma Recent Developments
  19. 8.4 CR Double-Crane
  20. 8.4.1 CR Double-Crane Company Information
  21. 8.4.2 CR Double-Crane Business Overview
  22. 8.4.3 CR Double-Crane Luseogliflozin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CR Double-Crane Luseogliflozin Product Portfolio
  24. 8.4.5 CR Double-Crane Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Luseogliflozin Value Chain Analysis
  2. 9.1.1 Luseogliflozin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Luseogliflozin Production Mode & Process
  6. 9.2 Luseogliflozin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Luseogliflozin Distributors
  9. 9.2.3 Luseogliflozin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst